SPX4,145.19-6.75 -0.16%
DIA327.97+0.61 0.19%
IXIC12,657.56-63.03 -0.50%

--B. Riley Lowers Intercept Pharmaceuticals' Price Target to $30 from $32, Keeps Buy Rating

--B. Riley Lowers Intercept Pharmaceuticals' Price Target to $30 from $32, Keeps Buy Rating

MT Newswires · 07/28/2022 06:02

Please log in to view news